Non-small cell lung cancer cell line · CELL-LINE
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Confirm a stable target identifier before relying on this context across project surfaces.
Confirm a stable target identifier before relying on this context across project surfaces.
Non-small cell lung cancer cell line
Review this target as Non-small cell lung cancer cell line.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Non-small cell lung cancer cell line as ChEMBL target CHEMBL615002. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether Non-small cell lung cancer cell line still has a stable protein naming contract across sources.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | Non-small cell lung cancer cell line |
| Target Type | CELL-LINE |
| Organism | None |
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | Non-small cell lung cancer cell line |
| UniProt Accession | N/A |
Non-small cell lung cancer cell line
Review this target as Non-small cell lung cancer cell line.
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL3353410 | 7.39 | IC50 | 41.0 | Approved |
| CHEMBL4285086 | 6.57 | IC50 | 270.0 | Preclinical |
| CHEMBL4288751 | 6.16 | IC50 | 690.0 | Preclinical |
| CHEMBL4278147 | 5.92 | IC50 | 1200.0 | Preclinical |
| CHEMBL4278841 | 5.82 | IC50 | 1500.0 | Preclinical |
| CHEMBL4278527 | 5.39 | IC50 | 4100.0 | Preclinical |
| CHEMBL4277811 | 5.28 | IC50 | 5200.0 | Preclinical |
| CHEMBL4277129 | 5.19 | IC50 | 6500.0 | Preclinical |
| CHEMBL4280622 | 5.17 | IC50 | 6700.0 | Preclinical |
| CHEMBL4293956 | 5.08 | IC50 | 8400.0 | Preclinical |
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| cell-based format | 8 | 21 | 4.7 |
| organism-based format | 4 | 0 | — |
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| cell-based format | 1 | 14 | 4.9 |